{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:40:49Z","timestamp":1794487249854,"version":"4.9.1"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05748-1","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T14:36:26Z","timestamp":1770215786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Malaria: a review on its current epidemiological status and management strategies"],"prefix":"10.1186","volume":"25","author":[{"given":"Geoffrey","family":"Okello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marique","family":"Aucamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"5748_CR1","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.14963.1","volume":"3","author":"P Doumbe-Belisse","year":"2018","unstructured":"Doumbe-Belisse P, Ngadjeu CS, Sonhafouo-Chiana N, Talipouo A, Djamouko-Djonkam L, Kopya E, et al. High malaria transmission sustained by Anopheles gambiae s.l. occurring both indoors and outdoors in the city of Yaound\u00e9, Cameroon. Wellcome Open Res. 2018;3:164.","journal-title":"Wellcome Open Res"},{"key":"5748_CR2","unstructured":"WHO. World Malaria Report 2023. www.who.int. World Health Organization: WHO; 2023. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2023. Accessed 15 Feb 2025."},{"issue":"9918","key":"5748_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/s0140-6736(13)60024-0","volume":"383","author":"NJ White","year":"2014","unstructured":"White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM. Malaria. Lancet. 2014;383(9918):723\u201335. https:\/\/doi.org\/10.1016\/s0140-6736(13)60024-0.","journal-title":"Lancet"},{"issue":"10","key":"5748_CR4","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1086\/652238","volume":"201","author":"X Su","year":"2010","unstructured":"Su X. Human malaria parasites: are we ready for a new species? J Infect Dis. 2010;201(10):1453\u20134.","journal-title":"J Infect Dis"},{"issue":"2","key":"5748_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.actatropica.2012.10.008","volume":"125","author":"S Antinori","year":"2013","unstructured":"Antinori S, Galimberti L, Milazzo L, Corbellino M. Plasmodium knowlesi: the emerging zoonotic malaria parasite. Acta Trop. 2013;125(2):191\u2013201.","journal-title":"Acta Trop"},{"issue":"3","key":"5748_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2022.104130","volume":"51","author":"F Nosten","year":"2022","unstructured":"Nosten F, Richard-Lenoble D, Danis M. A brief history of malaria. Presse Med. 2022;51(3):104130.","journal-title":"Presse Med"},{"issue":"3","key":"5748_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","volume":"167","author":"AF Cowman","year":"2016","unstructured":"Cowman AF, Healer J, Marapana D, Marsh K. Malaria: biology and disease. Cell. 2016;167(3):610\u201324.","journal-title":"Cell"},{"key":"5748_CR8","unstructured":"CDC. Malaria. Centers for disease control and prevention. 2024. https:\/\/www.cdc.gov\/dpdx\/malaria\/index.html. Accessed 22 May 2025."},{"key":"5748_CR9","unstructured":"Crutcher JM, Hoffman SL. Malaria. Nih.gov. University of Texas Medical Branch at Galveston; 1996. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK8584\/. Accessed 25 May 2025."},{"key":"5748_CR10","unstructured":"WHO. Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Policy brief on harnessing the strength of routine data for HIV surveillance. World Health Organization; 2023."},{"issue":"9753","key":"5748_CR11","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","volume":"376","author":"AM Dondorp","year":"2010","unstructured":"Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376(9753):1647\u201357.","journal-title":"Lancet"},{"key":"5748_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s44197-024-00228-2","volume":"14","author":"J Li","year":"2024","unstructured":"Li J, Docile HJ, Fisher D, Pronyuk K, Zhao L. Current status of malaria control and elimination in Africa: epidemiology, diagnosis, treatment, progress and challenges. J Epidemiol Glob Health. 2024;14:561\u201379.","journal-title":"J Epidemiol Glob Health"},{"key":"5748_CR13","unstructured":"WHO. World Malaria Report 2024. Who.int. World Health Organization: WHO; 2024. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2024. Accessed 15 Mar 2025."},{"key":"5748_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04131-8","author":"WC Lee","year":"2022","unstructured":"Lee WC, Cheong FW, Amir A, Lai MY, Tan JH, Phang WK, et al. Plasmodium knowlesi: the game changer for malaria eradication. Malar J. 2022. https:\/\/doi.org\/10.1186\/s12936-022-04131-8.","journal-title":"Malar J"},{"key":"5748_CR15","unstructured":"WHO. Countries and territories certified malaria-free by WHO. www.who.int. World Health Organization: WHO; 2025. https:\/\/www.who.int\/teams\/global-malaria-programme\/elimination\/countries-and-territories-certified-malaria-free-by-who. Accessed 25 July 2025."},{"issue":"8","key":"5748_CR16","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cid\/cix026","volume":"64","author":"RM Chico","year":"2017","unstructured":"Chico RM, Chaponda EB, Ariti C, Chandramohan D. Sulfadoxine-pyrimethamine exhibits dose-response protection against adverse birth outcomes related to malaria and sexually transmitted and reproductive tract infections. Clin Infect Dis. 2017;64(8):1043\u201351.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5748_CR17","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/S2214-109X(22)00431-4","volume":"11","author":"V Reddy","year":"2023","unstructured":"Reddy V, Weiss DJ, Rozier J, ter Kuile FO, Dellicour S. Global estimates of the number of pregnancies at risk of malaria from 2007 to 2020: a demographic study. Lancet Glob Health. 2023;11(1):e40\u20137.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"5748_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12936-018-2565-1","volume":"17","author":"AI Marealle","year":"2018","unstructured":"Marealle AI, Mbwambo DP, Mikomangwa WP, Kilonzi M, Mlyuka HJ, Mutagonda RF. A decade since sulfonamide-based anti-malarial medicines were limited for intermittent preventive treatment of malaria among pregnant women in Tanzania. Malar J. 2018;17(1):409.","journal-title":"Malar J"},{"issue":"207","key":"5748_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12936-018-2339-9","volume":"17","author":"L Sabin","year":"2018","unstructured":"Sabin L, Hecht EMS, Brooks MI, Singh MP, Yeboah-Antwi K, Rizal A, et al. Prevention and treatment of malaria in pregnancy: what do pregnant women and health care workers in East India know and do about it? Malar J. 2018;17(207):207.","journal-title":"Malar J"},{"issue":"1","key":"5748_CR20","doi-asserted-by":"publisher","DOI":"10.4102\/ajlm.v11i1.1842","volume":"11","author":"JN Enuma","year":"2022","unstructured":"Enuma JN, Sanni FO, Matur MB, Jean NE, Erhabor T, Egbulefu II. Malaria an opportunistic infection in HIV\/AIDS patients?\u2014a Nigerian experience. Afr J Lab Med. 2022;11(1):6.","journal-title":"Afr J Lab Med"},{"issue":"1","key":"5748_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1086\/498510","volume":"42","author":"DR Snydman","year":"2006","unstructured":"Snydman DR, Walker M, Kublin JG, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis. 2006;42(1):115\u201325.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5748_CR22","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/cid\/cix437","volume":"65","author":"K Wyss","year":"2017","unstructured":"Wyss K, W\u00e5ngdahl A, Vesterlund M, Hammar U, Dashti S, Naucler P, et al. Obesity and diabetes as risk factors for severe Plasmodium falciparum malaria: results from a Swedish nationwide study. Clin Infect Dis. 2017;65(6):949\u201358.","journal-title":"Clin Infect Dis"},{"key":"5748_CR23","unstructured":"WHO. World Malaria Report 2022. www.who.int. World Health Organization: WHO; 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240064898. Accessed 21 Mar 2025."},{"key":"5748_CR24","unstructured":"WHO. World Malaria Report 2018. www.who.int. World Health Organization: WHO; 2018. https:\/\/www.who.int\/publications\/i\/item\/9789241565653. Accessed 21 Mar 2025."},{"issue":"3","key":"5748_CR25","doi-asserted-by":"publisher","first-page":"e875","DOI":"10.1093\/cid\/ciac509","volume":"76","author":"A Kamau","year":"2022","unstructured":"Kamau A, Musau MP, Mwakio S, Amadi D, Nyaguara A, Bejon P, et al. Impact of intermittent presumptive treatment for malaria in pregnancy on hospital birth outcomes on the Kenyan coast. Clin Infect Dis. 2022;76(3):e875\u201383.","journal-title":"Clin Infect Dis"},{"key":"5748_CR26","unstructured":"WHO. This year\u2019s World Malaria Report at a Glance. www.who.int. World health Organization: WHO; 2018. https:\/\/www.who.int\/news\/item\/19-11-2018-this-year-s-world-malaria-report-at-a-glance. Accessed 21 Mar 2025."},{"key":"5748_CR27","unstructured":"CDC. Search Results | CDC. Cdc.gov. Centre for Disease Control and Prevention; 2023. https:\/\/search.cdc.gov\/search\/?query=Malaria%20control%20measures%202020&dpage=1. Accessed 25 July 2025."},{"issue":"Supplement_1","key":"5748_CR28","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1093\/infdis\/jiaa582","volume":"223","author":"MH Rodriguez","year":"2021","unstructured":"Rodriguez MH. Residual malaria: limitations of current vector control strategies to eliminate transmission in residual foci. J Infect Dis. 2021;223(Supplement_1):S55-60.","journal-title":"J Infect Dis"},{"issue":"1","key":"5748_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-3076-4","volume":"18","author":"AK Musiime","year":"2019","unstructured":"Musiime AK, Smith DL, Kilama M, Rek J, Arinaitwe E, Nankabirwa JI, et al. Impact of vector control interventions on malaria transmission intensity, outdoor vector biting rates and Anopheles mosquito species composition in Tororo, Uganda. Malar J. 2019;18(1):445.","journal-title":"Malar J"},{"key":"5748_CR30","unstructured":"WHO. Becoming malaria free by 2020. Who.int. World Health Organization: WHO; 2019. https:\/\/www.who.int\/news-room\/feature-stories\/detail\/becoming-malaria-free-by-2020. Accessed 23 May 2021."},{"key":"5748_CR31","unstructured":"WHO. Global Technical Strategy for Malaria 2016\u20132030, 2021 Update. www.who.int. World Health Organization: WHO; 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240031357. Accessed 12 Jan 2025."},{"key":"5748_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03527-8","volume":"19","author":"SMI Nasir","year":"2020","unstructured":"Nasir SMI, Amarasekara S, Wickremasinghe R, Fernando D, Udagama P. Prevention of re-establishment of malaria: historical perspective and future prospects. Malar J. 2020;19:452.","journal-title":"Malar J"},{"key":"5748_CR33","unstructured":"WHO. Timor-Leste Certified malaria-free by WHO. Who.int. World Health Organization: WHO; 2025. https:\/\/www.who.int\/news\/item\/24-07-2025-timor-leste-certified-malaria-free-by-who. Accessed 29 July 2025."},{"issue":"2","key":"5748_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016976","volume":"6","author":"AL Wilson","year":"2011","unstructured":"Wilson AL. A systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS ONE. 2011;6(2):e16976.","journal-title":"PLoS ONE"},{"key":"5748_CR35","unstructured":"CDC. Strategies for Reducing Malaria\u2019s Global Impact. Malaria. Centre for Disease Control and Prevention; 2024. https:\/\/www.cdc.gov\/malaria\/php\/public-health-strategy\/index.html. Accessed 16 Feb 2025."},{"key":"5748_CR36","unstructured":"WHO. Vector Control. www.who.int. World Health Organization: WHO; 2024. https:\/\/www.who.int\/teams\/control-of-neglected-tropical-diseases\/interventions\/strategies\/vector-control. Accessed 15 Feb 2025."},{"key":"5748_CR37","unstructured":"WHO. MAGICapp\u2014Making GRADE the Irresistible Choice\u2014Guidelines and Evidence Summaries. Magicapp.org. World Health Organization: WHO; 2024. https:\/\/app.magicapp.org\/#\/guideline\/LwRMXj. Accessed 13 Feb 2025."},{"issue":"1","key":"5748_CR38","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s13071-021-05026-4","volume":"14","author":"A Ahmed","year":"2021","unstructured":"Ahmed A, Khogali R, Elnour MAB, Nakao R, Salim B. Emergence of the invasive malaria vector Anopheles stephensi in Khartoum State, Central Sudan. Parasit Vectors. 2021;14(1):511.","journal-title":"Parasit Vectors"},{"key":"5748_CR39","first-page":"1060","volume":"27","author":"FG Tadesse","year":"2021","unstructured":"Tadesse FG, Ashine T, Teka H, Esayas E, Messenger LA, Chali W, et al. Anopheles stephensi mosquitoes as vectors of Plasmodium vivax and falciparum, Horn of Africa. Emerg Infect Dis J CDC. 2021;27:1060\u20136059.","journal-title":"Emerg Infect Dis J CDC"},{"issue":"1","key":"5748_CR40","doi-asserted-by":"publisher","first-page":"3144857","DOI":"10.1155\/jotm\/3144857","volume":"2025","author":"T Adugna","year":"2025","unstructured":"Adugna T. Challenges to malaria elimination in Ethiopia by 2030: a review. J Trop Med. 2025;2025(1):3144857.","journal-title":"J Trop Med"},{"issue":"40","key":"5748_CR41","doi-asserted-by":"publisher","first-page":"24900","DOI":"10.1073\/pnas.2003976117","volume":"117","author":"ME Sinka","year":"2020","unstructured":"Sinka ME, Pironon S, Massey NC, Longbottom J, Hemingway J, Moyes CL, et al. A new malaria vector in Africa: predicting the expansion range of Anopheles stephensi and identifying the urban populations at risk. Proc Natl Acad Sci U S A. 2020;117(40):24900\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5748_CR42","unstructured":"WHO. Vector alert: Anopheles stephensi invasion and spread in Africa and Sri Lanka. www.who.int. 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240067714. Accessed 30 Nov 2025."},{"issue":"1","key":"5748_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40794-022-00165-7","volume":"8","author":"EJ Kweka","year":"2022","unstructured":"Kweka EJ. Anopheles stephensi: a guest to watch in urban Africa. Trop Dis Travel Med Vaccines. 2022;8(1):7.","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"1","key":"5748_CR44","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12879-024-09213-3","volume":"24","author":"Q Liu","year":"2024","unstructured":"Liu Q, Wang M, Du YT, Xie JW, Yin ZG, Cai JH, et al. Possible potential spread of Anopheles stephensi, the Asian malaria vector. BMC Infect Dis. 2024;24(1):333.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"5748_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000633","volume":"18","author":"PA Hancock","year":"2020","unstructured":"Hancock PA, Hendriks CJM, Tangena JA, Gibson H, Hemingway J, Coleman M, et al. Mapping trends in insecticide resistance phenotypes in African malaria vectors. PLoS Biol. 2020;18(6):e3000633.","journal-title":"PLoS Biol"},{"issue":"8","key":"5748_CR46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2216142120","volume":"120","author":"C Whittaker","year":"2023","unstructured":"Whittaker C, Hamlet A, Sherrard-Smith E, Winskill P, Cuomo-Dannenburg G, Walker PGT, et al. Seasonal dynamics of Anopheles stephensi and its implications for mosquito detection and emergent malaria control in the Horn of Africa. Proc Natl Acad Sci U S A. 2023;120(8):e2216142120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5748_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"JM Oh","year":"2020","unstructured":"Oh JM, Venters CC, Di C, Pinto AM, Wan L, Younis I, et al. U1 snRNP regulates cancer cell migration and invasion in vitro. Nat Commun. 2020;11(1):1.","journal-title":"Nat Commun"},{"issue":"10","key":"5748_CR48","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1111\/ele.13335","volume":"22","author":"EA Mordecai","year":"2019","unstructured":"Mordecai EA. Thermal biology of mosquito-borne disease. Ecol Lett. 2019;22(10):1690\u2013708.","journal-title":"Ecol Lett"},{"issue":"6","key":"5748_CR49","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.pt.2021.03.003","volume":"37","author":"MC Wimberly","year":"2021","unstructured":"Wimberly MC, de Beurs KM, Loboda TV, Pan WK. Satellite observations and malaria: new opportunities for research and applications. Trends Parasitol. 2021;37(6):525\u201337.","journal-title":"Trends Parasitol"},{"issue":"197","key":"5748_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111017","volume":"197","author":"J Lubinda","year":"2021","unstructured":"Lubinda J, Haque U, Bi Y, Shad MY, Keellings D, Hamainza B, et al. Climate change and the dynamics of age-related malaria incidence in Southern Africa: a focus on Zambia. Environ Res. 2021;197(197):111017.","journal-title":"Environ Res"},{"issue":"7","key":"5748_CR51","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S2542-5196(21)00132-7","volume":"5","author":"FJ Col\u00f3n-Gonz\u00e1lez","year":"2021","unstructured":"Col\u00f3n-Gonz\u00e1lez FJ, Sewe MO, Tompkins AM, Sj\u00f6din H, Casallas A, Rockl\u00f6v J, et al. Projecting the risk of mosquito-borne diseases in a warmer and more populated world: a multi-model, multi-scenario intercomparison modelling study. Lancet Planet Health. 2021;5(7):404\u201314.","journal-title":"Lancet Planet Health"},{"key":"5748_CR52","unstructured":"WHO. WHO Publishes Recommendations on Two New Types of insecticide-treated Nets. www.who.int. World Health Organization: WHO; 2023. https:\/\/www.who.int\/news\/item\/14-03-2023-who-publishes-recommendations-on-two-new-types-of-insecticide-treated-nets. Accessed 23 Feb 2025."},{"key":"5748_CR53","unstructured":"WHO. Expanded Use of New dual-insecticide Nets Offers Hope for Malaria Control Efforts in Africa. Who.int. World Health Organization: WHO; 2025. https:\/\/www.who.int\/news-room\/feature-stories\/detail\/expanded-use-of-new-dual-insecticide-nets-offers-hope-for-malaria-control-efforts-in-africa. Accessed 21 Mar 2025."},{"issue":"1","key":"5748_CR54","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s13071-022-05454-w","volume":"15","author":"NJ Mbewe","year":"2022","unstructured":"Mbewe NJ, Rowland MW, Snetselaar J, Azizi S, Small G, Nimmo DD, et al. Efficacy of bednets with dual insecticide-treated netting (Interceptor\u00ae G2) on side and roof panels against Anopheles arabiensis in north-eastern Tanzania. Parasites Vectors. 2022;15(1):326.","journal-title":"Parasites Vectors"},{"issue":"1","key":"5748_CR55","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12936-025-05385-8","volume":"24","author":"QS Amorim","year":"2025","unstructured":"Amorim QS, Rodovalho CM, Loureiro AC, Serravale P, Bellinato DF, Guimar\u00e3es P, et al. First large-scale assessment of pyrethroid resistance in Anopheles darlingi (Diptera: Culicidae) in Brazil (2021\u20132024): a crucial step in informing decision-making in malaria control. Malar J. 2025;24(1):155.","journal-title":"Malar J"},{"key":"5748_CR56","volume-title":"Global plan for insecticide resistance management in malaria vectors","author":"WHO","year":"2012","unstructured":"WHO. Global plan for insecticide resistance management in malaria vectors. Geneva: World Health Organization; 2012."},{"issue":"5","key":"5748_CR57","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00436-016-4971-z","volume":"115","author":"G Benelli","year":"2016","unstructured":"Benelli G, Mehlhorn H. Declining malaria, rising of Dengue and Zika virus: insights for mosquito vector control. Parasitol Res. 2016;115(5):1747\u201354.","journal-title":"Parasitol Res"},{"issue":"5","key":"5748_CR58","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.sjbs.2018.06.007","volume":"26","author":"G Benelli","year":"2019","unstructured":"Benelli G. Managing mosquitoes and ticks in a rapidly changing world\u2014facts and trends. Saudi J Biol Sci. 2019;26(5):921\u20139.","journal-title":"Saudi J Biol Sci"},{"key":"5748_CR59","unstructured":"WHO. Evaluation of Genetically Modified Mosquitoes for the Control of vector-borne Diseases. www.who.int. World Health Organization: WHO; 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240013155. Accessed 12 Mar 2025."},{"key":"5748_CR60","unstructured":"CDC. Genetically Modified Mosquitoes. Mosquitoes. Centre for Disease Control and Prevention; 2024. https:\/\/www.cdc.gov\/mosquitoes\/mosquito-control\/genetically-modified-mosquitoes.html. Accessed 10 Aug 2025."},{"key":"5748_CR61","unstructured":"Brandon Levy. Mosquitos With Human Gene Hinder Malaria Transmission. NIH Intramural Research Program. 2022. https:\/\/irp.nih.gov\/blog\/post\/2022\/08\/mosquitos-with-human-gene-hinder-malaria-transmission. Accessed 17 Dec 2025."},{"key":"5748_CR62","unstructured":"WHO. Guidance Framework for Testing of Genetically Modified mosquitoes, Second Edition. www.who.int. World Health Organization: WHO; 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240025233. Accessed 17 Feb 2025."},{"issue":"1-2","key":"5748_CR63","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11248-023-00335-z","volume":"32","author":"SL James","year":"2023","unstructured":"James SL, Dass B, Quemada H. Regulatory and policy considerations for the implementation of gene drive-modified mosquitoes to prevent malaria transmission. Transgenic Res. 2023;32(1\u20132):17\u201332.","journal-title":"Transgenic Res"},{"issue":"1","key":"5748_CR64","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12936-024-05089-5","volume":"23","author":"I Kyomuhangi","year":"2024","unstructured":"Kyomuhangi I, Yukich J, Saili K, Orange E, Masuzyo MH, Mwenya M, et al. Evaluating trends in damage to attractive targeted sugar baits (ATSBs) deployed during the second year of a two-year Phase III trial in Western Zambia. Malaria J. 2024;23(1):263.","journal-title":"Malaria J"},{"issue":"1","key":"5748_CR65","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12936-024-05068-w","volume":"23","author":"E Orange","year":"2024","unstructured":"Orange E, Arnzen A, Muluma C, Akalalambili S, Tobolo T, Ndalama F, et al. Community acceptance of a novel malaria intervention, Attractive Targeted Sugar Baits, in the Zambia phase III trial. Malaria J. 2024;23(1):240.","journal-title":"Malaria J"},{"issue":"6","key":"5748_CR66","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMra1110897","volume":"370","author":"A Mills","year":"2014","unstructured":"Mills A. Health care systems in low- and middle-income countries. N Engl J Med. 2014;370(6):552\u20137.","journal-title":"N Engl J Med"},{"key":"5748_CR67","volume-title":"Implementation research in health: a practical guide","author":"DH Peters","year":"2013","unstructured":"Peters DH, Tran NT, Adam T. Implementation research in health: a practical guide. World Health Organization; 2013."},{"issue":"10","key":"5748_CR68","first-page":"724","volume":"82","author":"A Haines","year":"2004","unstructured":"Haines A, Kuruvilla S, Borchert M. Bridging the implementation gap between knowledge and action for health. Bull World Health Organ. 2004;82(10):724.","journal-title":"Bull World Health Organ"},{"issue":"11","key":"5748_CR69","doi-asserted-by":"publisher","first-page":"e1163","DOI":"10.1016\/S2214-109X(18)30398-X","volume":"6","author":"AK Rowe","year":"2018","unstructured":"Rowe AK, Rowe SY, Peters DH, Holloway KA, Chalker J, Ross-Degnan D. Effectiveness of strategies to improve health-care provider practices in low-income and middle-income countries: a systematic review. Lancet Glob Health. 2018;6(11):e1163\u201375.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"5748_CR70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/jech.56.2.119","volume":"56","author":"L Rychetnik","year":"2002","unstructured":"Rychetnik L, Frommer M, Hawe P, Shiell A. Criteria for evaluating evidence on public health interventions. J Epidemiol Community Health. 2002;56(2):119\u201327.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"5748_CR71","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12916-022-02324-1","volume":"20","author":"A Hamlet","year":"2022","unstructured":"Hamlet A, Dengela D, Eric Tongren J, Tadesse FG, Bousema T, Sinka ME, et al. The potential impact of Anopheles stephensi establishment on the transmission of Plasmodium falciparum in Ethiopia and prospective control measures. BMC Med. 2022;20(1):135.","journal-title":"BMC Med"},{"issue":"8","key":"5748_CR72","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.jval.2021.01.013","volume":"24","author":"L Conteh","year":"2021","unstructured":"Conteh L, Shuford K, Agboraw E, Kont M, Kolaczinski J, Patouillard E. Costs and cost-effectiveness of malaria control interventions: a systematic literature review. Value Health. 2021;24(8):1213\u201322.","journal-title":"Value Health"},{"issue":"1","key":"5748_CR73","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12936-025-05555-8","volume":"24","author":"KA Bogale","year":"2025","unstructured":"Bogale KA, Yenesew MA, Alemu K, Muchie KF, Asemahagn MA, Enbiale W. Facilitators and barriers of malaria prevention and treatment services to pregnant women in Ethiopia: a multi-level health system analysis, 2025. Malar J. 2025;24(1):337.","journal-title":"Malar J"},{"issue":"1","key":"5748_CR74","first-page":"29881","volume":"15","author":"AA Toure","year":"2025","unstructured":"Toure AA, Sidibe S, Magassouba AS, Beavogui AH, Conde M, Toure AF, et al. Inequity in the transmission of malaria infection among children and adolescents: a cohort study in rural Guinea. PubMed. 2025;15(1):29881\u201391.","journal-title":"PubMed"},{"issue":"5","key":"5748_CR75","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/heapol\/czr054","volume":"27","author":"L Paina","year":"2011","unstructured":"Paina L, Peters DH. Understanding pathways for scaling up health services through the lens of complex adaptive systems. Health Policy Plan. 2011;27(5):365\u201373.","journal-title":"Health Policy Plan"},{"key":"5748_CR76","unstructured":"CDC. Case Management: Diagnosis & Treatment. Malaria. World Health Organization: WHO; 2024. https:\/\/www.cdc.gov\/malaria\/php\/public-health-strategy\/case-diagnosis-treatment.html. Accessed 16 Feb 2025."},{"key":"5748_CR77","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-immunol-032713-120220","volume":"32","author":"PD Crompton","year":"2014","unstructured":"Crompton PD, Moebius J, Portugal S, Waisberg M, Hart G, Garver LS, et al. Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. Annu Rev Immunol. 2014;32:157\u201387.","journal-title":"Annu Rev Immunol"},{"key":"5748_CR78","unstructured":"WHO. WHO Guidelines for malaria, 3 June 2022. iriswhoint. 2022;WHO\/UCN\/GMP\/2022.01 Rev.2. https:\/\/iris.who.int\/handle\/10665\/354781. Accessed 15 Feb 2025."},{"issue":"7","key":"5748_CR79","volume":"2021","author":"EB Esu","year":"2021","unstructured":"Esu EB, Oringanje C, Meremikwu MM. Intermittent preventive treatment for malaria in infants. Cochrane Database Syst Rev. 2021;2021(7):CD011525.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"5748_CR80","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12936-022-04305-4","volume":"21","author":"JC Biteghe-Bi-Essone","year":"2022","unstructured":"Biteghe-Bi-Essone JC, Imboumy-Limoukou RK, Ekogha-Ovono JJ, Maghendji-Nzondo S, Sir-Ondo-Enguier PN, Oyegue LS, et al. Intermittent preventive treatment and malaria amongst pregnant women who give birth at the Centre Hospitalier R\u00e9gional Paul Moukambi de Koula-Moutou in southeastern Gabon. Malar J. 2022;21(1):315.","journal-title":"Malar J"},{"key":"5748_CR81","unstructured":"WHO. Updated WHO Recommendations for Malaria Chemoprevention among Children and Pregnant Women. www.who.int. World Health Organization: WHO; 2022. https:\/\/www.who.int\/news\/item\/03-06-2022-Updated-WHO-recommendations-for-malaria-chemoprevention-among-children-and-pregnant-women. Accessed 17 Mar 2025."},{"issue":"3","key":"5748_CR82","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/ebmed-2015-110173","volume":"20","author":"M Cairns","year":"2015","unstructured":"Cairns M, Walker PGT. Monthly malaria chemoprevention shows potential in an area of very high, perennial malaria transmission. Evid Based Med. 2015;20(3):110\u201320.","journal-title":"Evid Based Med"},{"issue":"12","key":"5748_CR83","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1473-3099(12)70222-0","volume":"12","author":"TP Eisele","year":"2012","unstructured":"Eisele TP, Larsen DA, Anglewicz PA, Keating J, Yukich J, Bennett A, et al. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis. 2012;12(12):942\u20139.","journal-title":"Lancet Infect Dis"},{"key":"5748_CR84","unstructured":"WHO. WHO Policy recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium Falciparum Malaria Control in Highly Seasonal Transmission Areas of the Sahel sub-region in Africa. Whoint. 2020;10665\/337982(10665\u2013337982). https:\/\/iris.who.int\/handle\/10665\/337978?locale-attribute=en&show=full. Accessed 15 Feb 2025."},{"issue":"1","key":"5748_CR85","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4269\/ajtmh.23-0481","volume":"110","author":"J Thwing","year":"2024","unstructured":"Thwing J, Williamson J, Cavros I, Gutman JR. Systematic review and meta-analysis of seasonal malaria chemoprevention. Am J Trop Med Hyg. 2024;110(1):20\u201331.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"5748_CR86","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/cpt.3471","volume":"117","author":"N Mwebaza","year":"2025","unstructured":"Mwebaza N, Roh ME, Geng YZ, Opio L, Opira B, Marzan F, et al. Drug-drug interaction between dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine during malaria chemoprevention in pregnant women. Clin Pharmacol Ther. 2025;117(2):506\u201314.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"5748_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002212","volume":"14","author":"RM Hoglund","year":"2017","unstructured":"Hoglund RM, Workman L, Edstein MD, Thanh NX, Quang NN, Zongo I, et al. Population pharmacokinetic properties of piperaquine in falciparum malaria: an individual participant data meta-analysis. PLoS Med. 2017;14(1):e1002212.","journal-title":"PLoS Med"},{"issue":"3","key":"5748_CR88","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cid\/civ881","volume":"62","author":"M Desai","year":"2016","unstructured":"Desai M, Gutman J, Taylor SM, Wiegand RE, Khairallah C, Kayentao K, et al. Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight. Clin Infect Dis. 2016;62(3):323\u201333.","journal-title":"Clin Infect Dis"},{"key":"5748_CR89","doi-asserted-by":"publisher","first-page":"105009","DOI":"10.1016\/j.meegid.2021.105009","volume":"94","author":"NK Kayiba","year":"2021","unstructured":"Kayiba NK, Yobi DM, Tchakounang VR, Mvumbi DM, Kabututu PZ, Devleesschauwer B, et al. Evaluation of the usefulness of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a context with increased resistance of Plasmodium falciparum in Kingasani Hospital, Kinshasa in the Democratic Republic of Congo. Infect Genet Evol. 2021;94:105009\u201319.","journal-title":"Infect Genet Evol"},{"issue":"7","key":"5748_CR90","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1365-3156.2011.02765.x","volume":"16","author":"RM Chico","year":"2011","unstructured":"Chico RM, Chandramohan D. Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy. Trop Med Int Health. 2011;16(7):774\u201385.","journal-title":"Trop Med Int Health"},{"issue":"1","key":"5748_CR91","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/1475-2875-7-255","volume":"7","author":"RM Chico","year":"2008","unstructured":"Chico RM, Pittrof R, Greenwood B, Chandramohan D. Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy. Malar J. 2008;7(1):255.","journal-title":"Malar J"},{"key":"5748_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.966402","volume":"10","author":"SA Sundararaman","year":"2022","unstructured":"Sundararaman SA, Odom John AR. Prevention of malaria in pregnancy: the threat of sulfadoxine-pyrimethamine resistance. Front Pediatr. 2022;10:966402.","journal-title":"Front Pediatr"},{"issue":"8","key":"5748_CR93","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-005877","volume":"6","author":"DK Dosoo","year":"2021","unstructured":"Dosoo DK, Malm K, Oppong FB, Gyasi R, Oduro A, Williams J, et al. Effectiveness of intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) in Ghana. BMJ Glob Health. 2021;6(8):e005877.","journal-title":"BMJ Glob Health"},{"key":"5748_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6712685","volume":"2019","author":"F Anto","year":"2019","unstructured":"Anto F, Agongo IH, Asoala V, Awini E, Oduro AR. Intermittent preventive treatment of malaria in pregnancy: assessment of the sulfadoxine-pyrimethamine three-dose policy on birth outcomes in rural northern Ghana. J Trop Med. 2019;2019:1\u201310.","journal-title":"J Trop Med"},{"issue":"1","key":"5748_CR95","doi-asserted-by":"publisher","first-page":"19034","DOI":"10.1038\/s41598-019-55046-5","volume":"9","author":"I Quakyi","year":"2019","unstructured":"Quakyi I, Tornyigah B, Houze P, Kusi KA, Coleman N, Escriou G, et al. High uptake of intermittent preventive treatment of malaria in pregnancy is associated with improved birth weight among pregnant women in Ghana. Sci Rep. 2019;9(1):19034.","journal-title":"Sci Rep"},{"issue":"6","key":"5748_CR96","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jama.2012.216231","volume":"309","author":"K Kayentao","year":"2013","unstructured":"Kayentao K, Garner P, van Maria Eijk A, Naidoo I, Roper C, Mulokozi A, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa. JAMA. 2013;309(6):594.","journal-title":"JAMA"},{"issue":"1","key":"5748_CR97","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1038\/s41598-019-38821-2","volume":"9","author":"HW Unger","year":"2019","unstructured":"Unger HW, Hansa AP, Buffet C, Hasang W, Teo A, Randall L, et al. Sulphadoxine-pyrimethamine plus azithromycin may improve birth outcomes through impacts on inflammation and placental angiogenesis independent of malarial infection. Sci Rep. 2019;9(1):2260.","journal-title":"Sci Rep"},{"issue":"3","key":"5748_CR98","first-page":"148","volume":"5","author":"H Maiga","year":"2020","unstructured":"Maiga H, Barger B, Sagara I, Guindo A, Traore OB, Tekete M, et al. Impact of three-year intermittent preventive treatment using artemisinin-based combination therapies on malaria morbidity in Malian schoolchildren. Trop Med Infect Dis. 2020;5(3):148.","journal-title":"Trop Med Infect Dis"},{"issue":"1","key":"5748_CR99","doi-asserted-by":"publisher","first-page":"2231257","DOI":"10.1080\/16549716.2023.2231257","volume":"16","author":"SL Eisenberg","year":"2023","unstructured":"Eisenberg SL, Krieger AE. A comprehensive approach to optimizing malaria prevention in pregnant women: evaluating the efficacy, cost-effectiveness, and resistance of IPTp-SP and IPTp-DP. Glob Health Action. 2023;16(1):2231257.","journal-title":"Glob Health Action"},{"issue":"8","key":"5748_CR100","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1128\/AAC.48.8.2924-2929.2004","volume":"48","author":"AP Alker","year":"2004","unstructured":"Alker AP, Mwapasa V, Meshnick SR. Rapid real-time PCR genotyping of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum. Antimicrob Agents Chemother. 2004;48(8):2924\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"5748_CR101","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","volume":"16","author":"K Haldar","year":"2018","unstructured":"Haldar K, Bhattacharjee S, Safeukui I. Drug resistance in Plasmodium. Nat Rev Microbiol. 2018;16(3):156\u201370.","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"5748_CR102","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.clinthera.2012.10.001","volume":"34","author":"YM Liu","year":"2012","unstructured":"Liu YM, Zhang KE, Liu Y, Zhang HC, Song YX, Pu HH, et al. Pharmacokinetic properties and bioequivalence of two sulfadoxine\/pyrimethamine fixed-dose combination tablets: a parallel-design study in healthy Chinese male volunteers. Clin Ther. 2012;34(11):2212\u201320.","journal-title":"Clin Ther"},{"key":"5748_CR103","volume":"2","author":"MM Meremikwu","year":"2012","unstructured":"Meremikwu MM, Donegan S, Sinclair D, Esu E, Oringanje C. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database of Syst Rev. 2012;2:CD003756.","journal-title":"Cochrane Database of Syst Rev"},{"issue":"3","key":"5748_CR104","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ijantimicag.2016.11.017","volume":"49","author":"J Matangila","year":"2017","unstructured":"Matangila J, Doua JY, Mitashi P, Inoc\u00eancio R, Lutumba P, Van Geertruyden JP. Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine\/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial. Int J Antimicrob Agents. 2017;49(3):339\u201347.","journal-title":"Int J Antimicrob Agents"},{"key":"5748_CR105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010767.pub2","author":"M Athuman","year":"2015","unstructured":"Athuman M, Kabanywanyi AM, Rohwer AC. Intermittent preventive antimalarial treatment for children with anaemia. Cochrane Database Syst Rev. 2015. https:\/\/doi.org\/10.1002\/14651858.CD010767.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"5748_CR106","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1365-3156.2009.02294.x","volume":"14","author":"B Barger","year":"2009","unstructured":"Barger B, Maiga H, Traore OB, Tekete M, Tembine I, Dara A, et al. Intermittent preventive treatment using artemisinin-based combination therapy reduces malaria morbidity among school-aged children in Mali. Trop Med Int Health. 2009;14(7):784\u201391.","journal-title":"Trop Med Int Health"},{"issue":"1","key":"5748_CR107","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/S2214-109X(23)00492-8","volume":"12","author":"KS Phiri","year":"2024","unstructured":"Phiri KS, Khairallah C, Kwambai TK, Bojang K, Dhabangi A, Opoka R, et al. Post-discharge malaria chemoprevention in children admitted with severe anaemia in malaria-endemic settings in Africa: a systematic review and individual patient data meta-analysis of randomised controlled trials. Lancet Glob Health. 2024;12(1):e33-44.","journal-title":"Lancet Glob Health"},{"key":"5748_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-023-04810-0","author":"J Hill","year":"2024","unstructured":"Hill J, Accrombessi M, Briand V, Dhabangi A, Hill J, Hoyt J, et al. Implementation of post-discharge malaria chemoprevention (PDMC) in Benin, Kenya, Malawi, and Uganda: stakeholder engagement meeting report. Malaria J. 2024. https:\/\/doi.org\/10.1186\/s12936-023-04810-0.","journal-title":"Malaria J"},{"issue":"1","key":"5748_CR109","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4269\/ajtmh.14-0254","volume":"93","author":"G Newby","year":"2015","unstructured":"Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. Am Soc Trop Med Hyg. 2015;93(1):125\u201334.","journal-title":"Am Soc Trop Med Hyg"},{"key":"5748_CR110","unstructured":"WHO. The Role of Mass Drug administration, Mass Screening and treatment, and Focal Screening and Treatment for malaria: Recommendations. Whoint. 2015;2015.8. https:\/\/iris.who.int\/handle\/10665\/338500. Accessed 12 May 2025."},{"issue":"1","key":"5748_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001157","volume":"9","author":"T Smith","year":"2012","unstructured":"Smith T, Ross A, Maire N, Chitnis N, Studer A, Hardy D, et al. Ensemble modeling of the likely public health impact of a pre-erythrocytic malaria vaccine. PLoS Med. 2012;9(1):e1001157.","journal-title":"PLoS Med"},{"key":"5748_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-05096-6","author":"M Reynders","year":"2024","unstructured":"Reynders M, Tweneboah A, Abbas DA, Opoku Afriyie S, Nketsiah SN, Badu K, et al. Challenges in diagnosis of clinical and subclinical Plasmodium falciparum infections in Ghana and feasibility of reactive interventions to shrink the subclinical reservoir. Malar J. 2024. https:\/\/doi.org\/10.1186\/s12936-024-05096-6.","journal-title":"Malar J"},{"issue":"1","key":"5748_CR113","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12879-025-10897-4","volume":"25","author":"AH Mutala","year":"2025","unstructured":"Mutala AH, Afriyie SO, Addison TK, Antwi KB, Troth EV, Vera-Arias CA, et al. The burden and diagnostic challenges of subclinical Plasmodium falciparum infections in Southern Ghana. BMC Infect Dis. 2025;25(1):543\u201353.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"5748_CR114","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12936-019-3090-6","volume":"19","author":"LP Kojom","year":"2020","unstructured":"Kojom LP, Singh V. Prevalence of Plasmodium falciparum field isolates with deletions in histidine-rich protein 2 and 3 genes in context with sub-Saharan Africa and India: a systematic review and meta-analysis. Malar J. 2020;19(1):46.","journal-title":"Malar J"},{"issue":"1","key":"5748_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04051-7","volume":"21","author":"A Jejaw Zeleke","year":"2022","unstructured":"Jejaw Zeleke A, Hailu A, Bayih AG, Kefale M, Amare AT, Tegegne Y, et al. Plasmodium falciparum histidine-rich protein 2 and 3 genes deletion in global settings (2010\u20132021): a systematic review and meta-analysis. Malar J. 2022;21(1):26.","journal-title":"Malar J"},{"issue":"12","key":"5748_CR116","doi-asserted-by":"publisher","DOI":"10.4081\/jphia.2023.2478","volume":"14","author":"B Bonkoungou","year":"2023","unstructured":"Bonkoungou B, Utunen H, Talisuna AO, O\u2019Connell G, Koua E, Chamla DD, et al. Online capacity building for the health workforce: the case of the integrated disease surveillance and response for the African region. J Public Health Afr. 2023;14(12):11.","journal-title":"J Public Health Afr"},{"key":"5748_CR117","doi-asserted-by":"publisher","first-page":"10483","DOI":"10.1016\/S0140-6736(25)00038-8","volume":"405","author":"DJ Weiss","year":"2025","unstructured":"Weiss DJ, Dzianach PA, Saddler A, Lubinda J, Browne A, McPhail M, et al. Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum and Plasmodium vivax malaria, 2000\u201322: a spatial and temporal modelling study. Lancet. 2025;405:10483.","journal-title":"Lancet"},{"issue":"1","key":"5748_CR118","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3201\/eid2901.220775","volume":"29","author":"I de la Molina- Fuente","year":"2023","unstructured":"de la Molina- Fuente I, Benito MJS, Flevaud L, Ousley J, Pasquale HA, Julla A, et al. Plasmodium falciparum pfhrp2 and pfhrp3 Gene Deletions in Malaria-Hyperendemic Region, South Sudan. Emerg Infect Dis. 2023;29(1):154\u20139.","journal-title":"Emerg Infect Dis"},{"key":"5748_CR119","unstructured":"Global Malaria Programme (GMP. Response plan to pfhrp2 gene deletions, second edition. Who.int. World Health Organization; 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240101838."},{"key":"5748_CR120","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.puhe.2023.10.008","volume":"225","author":"ACK Lee","year":"2023","unstructured":"Lee ACK, Iversen BG, Lynes S, Rahman-Shepherd A, Erondu NA, Khan MS, et al. The state of integrated disease surveillance in seven countries: a synthesis report. Public Health. 2023;225:141\u20136.","journal-title":"Public Health"},{"issue":"4","key":"5748_CR121","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s10900-019-00620-1","volume":"44","author":"CL Connell","year":"2019","unstructured":"Connell CL, Wang SC, Crook L, Yadrick K. Barriers to healthcare seeking and provision among African American adults in the rural Mississippi Delta region: community and provider perspectives. J Community Health. 2019;44(4):636\u201345.","journal-title":"J Community Health"},{"issue":"1","key":"5748_CR122","doi-asserted-by":"publisher","first-page":"8170","DOI":"10.1038\/ncomms9170","volume":"6","author":"E Cameron","year":"2015","unstructured":"Cameron E, Battle KE, Bhatt S, Weiss DJ, Bisanzio D, Mappin B, et al. Defining the relationship between infection prevalence and clinical incidence of Plasmodium falciparum malaria. Nat Commun. 2015;6(1):8170.","journal-title":"Nat Commun"},{"key":"5748_CR123","unstructured":"Day N, Dondorp, Arjen M, Limmathurotsakul D, Maude R, Tarning J, Cheah PY, et al. MORU Tropical Health Network Annual Report 2021. Zenodo (CERN European Organization for Nuclear Research). 2022. https:\/\/ora.ox.ac.uk\/objects\/uuid:52a85d6d-f57b-4d73-be12-b361325aa161. Accessed 12 May 2025."},{"issue":"2","key":"5748_CR124","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/bcp.14474","volume":"88","author":"B Hanboonkunupakarn","year":"2020","unstructured":"Hanboonkunupakarn B, White NJ. Advances and roadblocks in the treatment of malaria. Br J Clin Pharmacol. 2020;88(2):374\u201382.","journal-title":"Br J Clin Pharmacol"},{"key":"5748_CR125","unstructured":"WHO. Multiple first-line therapies as part of the response to antimalarial drug resistance. World Health Organization; 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240103603. Accessed 20 Feb 2025."},{"issue":"2","key":"5748_CR126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002745","volume":"16","author":"L von Seidlein","year":"2019","unstructured":"von Seidlein L, Peto TJ, Landier J, Nguyen TN, Tripura R, Phommasone K, et al. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: a cluster randomised trial. PLoS Med. 2019;16(2):e1002745.","journal-title":"PLoS Med"},{"key":"5748_CR127","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2012.073","author":"RF Schumacher","year":"2012","unstructured":"Schumacher RF, Spinelli E. Malaria in children. Mediterr J Hematol Infect Dis. 2012. https:\/\/doi.org\/10.4084\/mjhid.2012.073.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"1","key":"5748_CR128","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/1475-2875-10-263","volume":"10","author":"CA Morris","year":"2011","unstructured":"Morris CA, Duparc S, Borghini-Fuhrer I, Jung D, Shin CS, Fleckenstein L. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration. Malar J. 2011;10(1):263.","journal-title":"Malar J"},{"issue":"2","key":"5748_CR129","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/01.pec.0000199562.56640.1c","volume":"22","author":"D Agrawal","year":"2006","unstructured":"Agrawal D, Teach SJ. Evaluation and management of a child with suspected malaria. Pediatr Emerg Care. 2006;22(2):127\u201333.","journal-title":"Pediatr Emerg Care"},{"issue":"10","key":"5748_CR130","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/cid\/ciab133","volume":"73","author":"C Roussel","year":"2021","unstructured":"Roussel C, Ndour PA, Kendjo \u00c9, Larr\u00e9ch\u00e9 S, Taieb A, Henry B, et al. Intravenous artesunate for the treatment of severe imported malaria: implementation, efficacy, and safety in 1391 patients. Clin Infect Dis. 2021;73(10):1795\u2013804.","journal-title":"Clin Infect Dis"},{"key":"5748_CR131","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c1350","volume":"340","author":"B Nadjm","year":"2010","unstructured":"Nadjm B, Amos B, Mtove G, Ostermann J, Chonya S, Wangai H, et al. WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense Plasmodium falciparum transmission: prospective study. BMJ. 2010;340:c1350.","journal-title":"BMJ"},{"issue":"1","key":"5748_CR132","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2018","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2018;18(1):41\u201358.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"5748_CR133","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210724","volume":"218","author":"HD Chien","year":"2021","unstructured":"Chien HD, Pantaleo A, Kesely KR, Noomuna P, Putt KS, Tuan TA, et al. Imatinib augments standard malaria combination therapy without added toxicity. J Exp Med. 2021;218(10):e20210724.","journal-title":"J Exp Med"},{"issue":"8","key":"5748_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26082304","volume":"26","author":"L de Pessanha Carvalho","year":"2021","unstructured":"de Pessanha Carvalho L, Kreidenweiss A, Held J. Drug repurposing: a review of old and new antibiotics for the treatment of malaria: identifying antibiotics with a fast onset of antiplasmodial action. Molecules. 2021;26(8):2304.","journal-title":"Molecules"},{"issue":"24","key":"5748_CR135","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1016\/j.bmc.2016.07.029","volume":"24","author":"SK Tanaka","year":"2016","unstructured":"Tanaka SK, Steenbergen J, Villano S. Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic. Bioorg Med Chem. 2016;24(24):6409\u201319.","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"5748_CR136","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12936-025-05448-w","volume":"24","author":"MS Madejczyk","year":"2025","unstructured":"Madejczyk MS, Leed SE, Kudyba K, Roth A, Martin ML, Lee P, et al. In vitro activity and in vivo efficacy of omadacycline against Plasmodium species. Malar J. 2025;24(1):194.","journal-title":"Malar J"},{"issue":"8","key":"5748_CR137","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","volume":"21","author":"A Uwimana","year":"2021","unstructured":"Uwimana A, Umulisa N, Venkatesan M, Svigel SS, Zhou Z, Munyaneza T, et al. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect Dis. 2021;21(8):1120\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"5748_CR138","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa2211803","volume":"389","author":"MD Conrad","year":"2023","unstructured":"Conrad MD, Asua V, Garg S, Giesbrecht D, Niar\u00e9 K, Smith S, et al. Evolution of partial resistance to artemisinins in malaria parasites in Uganda. N Engl J Med. 2023;389(8):722\u201332.","journal-title":"N Engl J Med"},{"issue":"8","key":"5748_CR139","doi-asserted-by":"publisher","first-page":"e1010317","DOI":"10.1371\/journal.pcbi.1010317","volume":"18","author":"JA Flegg","year":"2022","unstructured":"Flegg JA, Humphreys GS, Montanez B, Strickland T, Jacome-Meza ZJ, Barnes KI, et al. Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990\u20132020. PLoS Comput Biol. 2022;18(8):e1010317\u201327.","journal-title":"PLoS Comput Biol"},{"issue":"7","key":"5748_CR140","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025619","volume":"7","author":"D Menard","year":"2017","unstructured":"Menard D, Dondorp A. Antimalarial drug resistance: a threat to malaria elimination. Cold Spring Harb Perspect Med. 2017;7(7):a025619.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"9","key":"5748_CR141","doi-asserted-by":"publisher","first-page":"ofaf508","DOI":"10.1093\/ofid\/ofaf508","volume":"12","author":"A Walker","year":"2025","unstructured":"Walker A, Ross A, Nsanzabana C. Changes in the prevalence of antimalarial partner drug resistance markers and policy in 6 sub-Saharan African countries from 2000 to 2021: a systematic review. Open Forum Infect Dis. 2025;12(9):ofaf508\u201318.","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"5748_CR142","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","volume":"19","author":"MD Conrad","year":"2019","unstructured":"Conrad MD, Rosenthal PJ. Antimalarial drug resistance in Africa: the calm before the storm? Lancet Infect Dis. 2019;19(10):e338\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"19","key":"5748_CR143","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.3390\/jcm13195680","volume":"13","author":"M Thellier","year":"2024","unstructured":"Thellier M, Jessicka A, Tantaoui I. Global fight against malaria: goals and achievements 1900\u20132022. J Clin Med. 2024;13(19):5680.","journal-title":"J Clin Med"},{"key":"5748_CR144","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11908-023-00805-9","volume":"25","author":"M Gonz\u00e1lez-Sanz","year":"2023","unstructured":"Gonz\u00e1lez-Sanz M, Berzosa P, Norman FF. Updates on malaria epidemiology and prevention strategies. Curr Infect Dis Rep. 2023;25:131\u20139.","journal-title":"Curr Infect Dis Rep"},{"key":"5748_CR145","unstructured":"WHO. Life-saving malaria vaccines reach children in 17 endemic countries in 2024. Who.int. World Health Organization: WHO; 2024. https:\/\/www.who.int\/news-room\/feature-stories\/detail\/life-saving-malaria-vaccines-reach-children-in-17-endemic-countries-in-2024. Accessed 20 Feb 2025."},{"key":"5748_CR146","unstructured":"WHO. Malaria vaccines (RTS,S and R21). www.who.int. World Health Organization: WHO; 2024. https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/q-a-on-rts-s-malaria-vaccine. Accessed 25 Feb 2025."},{"issue":"3","key":"5748_CR147","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.parint.2007.04.002","volume":"56","author":"P Sinnis","year":"2007","unstructured":"Sinnis P, Coppi A. A long and winding road: the Plasmodium sporozoite\u2019s journey in the mammalian host. Parasitol Int. 2007;56(3):171\u20138.","journal-title":"Parasitol Int"},{"issue":"4","key":"5748_CR148","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.immuni.2020.08.014","volume":"53","author":"TW Lawrence","year":"2020","unstructured":"Lawrence TW, Lais SP, Flores-Garcia Y, Zavala F, Joseph RF. A potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver. Immunity. 2020;53(4):733-744.e8.","journal-title":"Immunity"},{"issue":"1","key":"5748_CR149","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1172\/JCI70349","volume":"124","author":"L Foquet","year":"2013","unstructured":"Foquet L, Hermsen CC, van Gemert GJ, Van Braeckel E, Weening KE, Sauerwein R, et al. Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection. J Clin Invest. 2013;124(1):140\u20134.","journal-title":"J Clin Invest"},{"issue":"48","key":"5748_CR150","doi-asserted-by":"publisher","first-page":"E10438","DOI":"10.1073\/pnas.1715812114","volume":"114","author":"D Oyen","year":"2017","unstructured":"Oyen D, Torres JP, Wille-Reece U, Ockenhouse CF, Emerling D, Glanville J, et al. Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein. Proc Natl Acad Sci USA. 2017;114(48):E10438\u201345.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"5748_CR151","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nm.4512","volume":"24","author":"NK Kisalu","year":"2018","unstructured":"Kisalu NK, Idris AH, Weidle C, Flores-Garcia Y, Flynn BJ, Sack BK, et al. A human monoclonal antibody prevents malaria infection and defines a new site of vulnerability on Plasmodium falciparum circumsporozoite protein. Nat Med. 2018;24(4):408\u201316.","journal-title":"Nat Med"},{"issue":"9","key":"5748_CR152","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa2034031","volume":"385","author":"MR Gaudinski","year":"2021","unstructured":"Gaudinski MR, Berkowitz NM, Idris AH, Coates EE, Holman LA, Mendoza F, et al. A monoclonal antibody for malaria prevention. N Engl J Med. 2021;385(9):803\u201314.","journal-title":"N Engl J Med"},{"issue":"3","key":"5748_CR153","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.143958","volume":"6","author":"NK Kisalu","year":"2020","unstructured":"Kisalu NK, Pereira LD, Ernste K, Flores-Garcia Y, Idris AH, Asokan M, et al. Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention. JCI Insight. 2020;6(3):e143958.","journal-title":"JCI Insight"},{"key":"5748_CR154","unstructured":"WHO. Guidelines for malaria, 14 March 2023. iriswhoint. 2023;2023.01. https:\/\/iris.who.int\/handle\/10665\/366432. Accessed 17 Mar 2025."},{"issue":"7","key":"5748_CR155","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1473-3099(19)30165-3","volume":"19","author":"A Haakenstad","year":"2019","unstructured":"Haakenstad A, Harle AC, Tsakalos G, Micah AE, Tao T, Anjomshoa M, et al. Tracking spending on malaria by source in 106 countries, 2000\u201316: an economic modelling study. Lancet Infect Dis. 2019;19(7):703\u201316.","journal-title":"Lancet Infect Dis"},{"key":"5748_CR156","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04303-6","author":"MV Andrade","year":"2022","unstructured":"Andrade MV, Noronha K, Diniz BPC, Guedes G, Carvalho LR, Silva VA, et al. The economic burden of malaria: a systematic review. Malar J. 2022. https:\/\/doi.org\/10.1186\/s12936-022-04303-6.","journal-title":"Malar J"},{"issue":"1","key":"5748_CR157","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12936-023-04540-3","volume":"22","author":"HN Hiruy","year":"2023","unstructured":"Hiruy HN, Irish SR, Abdelmenan S, Wuletaw Y, Zewde A, Woyessa A, et al. Durability of long-lasting insecticidal nets (LLINs) in Ethiopia. Malaria J. 2023;22(1):109.","journal-title":"Malaria J"},{"issue":"1","key":"5748_CR158","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1475-2875-9-144","volume":"9","author":"J Chuma","year":"2010","unstructured":"Chuma J, Okungu V, Molyneux C. Barriers to prompt and effective malaria treatment among the poorest population in Kenya. Malar J. 2010;9(1):144.","journal-title":"Malar J"},{"key":"5748_CR159","unstructured":"WHO. A Framework for Malaria Elimination. www.who.int. World Health Organization: WHO; 2017. https:\/\/www.who.int\/publications\/i\/item\/9789241511988. Accessed 25 Feb 2025"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05748-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05748-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05748-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:03:38Z","timestamp":1772629418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-025-05748-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":159,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5748"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05748-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}